ArticleMolecular genetics & genomic medicine2026
Rare Biallelic CTU2 Variants in an Individual With CAKUT: Clinical Characterization and Minigene Splicing Analysis.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCongenital anomalies of the kidney and urinary tract (CAKUT) are clinically heterogeneous and remain genetically unexplained in many patients. Biallelic variants in CTU2 have been reported in DREAM-PL syndrome, a severe multisystem disorder characterized by dysmorphic facies, renal agenesis, ambiguous genitalia, microcephaly, polydactyly, and lissencephaly. However, to date, there have been no reports on the involvement of CTU2 in CAKUT.
methodsExome sequencing (ES) was performed in 200 patients with CAKUT. Candidate CTU2 variants were validated by Sanger sequencing, and segregation analysis was conducted in available family members. Variant rarity was assessed using public population databases and an in-house cohort of 200 ethnically matched kidney disease-free controls. Potential functional effects were evaluated using in silico prediction tools and minigene splicing assays.
resultsThe affected individual, who had a diagnosis of CAKUT, presented with bilateral hydronephrosis, chronic kidney disease, and focal segmental glomerulosclerosis. Genetic analysis revealed compound heterozygous CTU2 variants, NM_001012759.3: c.913C>T, p.(Arg305Trp), and c.1492C>G, p.(Gln498Glu), which were inherited from his father and mother, respectively. Both variants were rare and had not been previously reported in CTU2-related disease. In silico splicing analyses suggested that both variants may alter putative exonic splicing enhancers (ESE) motifs. Minigene splicing assays showed that c.913C>T altered pre-mRNA splicing by increasing exon 9 skipping, whereas c.1492C>G had no statistically significant effect on exon inclusion.
conclusionThis study identifies two rare CTU2 variants in an individual with renal-predominant CAKUT and provides in vitro evidence that c.913C>T partially alters splicing. While these findings do not establish CTU2 as a definitive cause of isolated CAKUT, they support further case collection and kidney-relevant functional studies of CTU2 in renal developmental phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.